OA11247A - Delayed-release dosage forms of sertraline - Google Patents

Delayed-release dosage forms of sertraline Download PDF

Info

Publication number
OA11247A
OA11247A OA9900307A OA9900307A OA11247A OA 11247 A OA11247 A OA 11247A OA 9900307 A OA9900307 A OA 9900307A OA 9900307 A OA9900307 A OA 9900307A OA 11247 A OA11247 A OA 11247A
Authority
OA
OAPI
Prior art keywords
dosage form
sertraline
daim
core
delayed
Prior art date
Application number
OA9900307A
Other languages
English (en)
Inventor
William John Curatolo
Hylar Lewis Friedman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11247(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11247A publication Critical patent/OA11247A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
OA9900307A 1997-07-01 1999-12-23 Delayed-release dosage forms of sertraline OA11247A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
OA11247A true OA11247A (en) 2002-11-19

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900307A OA11247A (en) 1997-07-01 1999-12-23 Delayed-release dosage forms of sertraline

Country Status (41)

Country Link
EP (1) EP1007024B1 (es)
JP (1) JP3786715B2 (es)
KR (1) KR100369698B1 (es)
CN (4) CN1494899A (es)
AP (1) AP1199A (es)
AR (1) AR038394A2 (es)
AT (1) ATE245415T1 (es)
AU (1) AU727152B2 (es)
BG (1) BG64742B1 (es)
BR (1) BR9809895A (es)
CA (1) CA2290969C (es)
DE (1) DE69816624T2 (es)
DK (1) DK1007024T3 (es)
DZ (1) DZ2547A1 (es)
EA (1) EA001906B1 (es)
ES (1) ES2202858T3 (es)
GT (1) GT199800091A (es)
HK (1) HK1027982A1 (es)
HN (1) HN1998000099A (es)
HR (1) HRP980376B1 (es)
HU (1) HUP0301787A3 (es)
ID (1) ID23187A (es)
IL (2) IL152304A0 (es)
IS (1) IS5267A (es)
MA (1) MA24585A1 (es)
NO (1) NO996519L (es)
NZ (1) NZ501249A (es)
OA (1) OA11247A (es)
PA (1) PA8454201A1 (es)
PE (1) PE84399A1 (es)
PL (1) PL337799A1 (es)
PT (1) PT1007024E (es)
SI (1) SI1007024T1 (es)
SK (1) SK173299A3 (es)
TN (1) TNSN98122A1 (es)
TR (1) TR199903295T2 (es)
TW (1) TW575437B (es)
UA (1) UA63953C2 (es)
UY (1) UY25068A1 (es)
WO (1) WO1999001122A1 (es)
ZA (1) ZA985710B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1126826E (pt) 1998-11-02 2008-11-25 Elan Pharma Int Ltd Composição de metilfenidato de libertação modificada multiparticulada
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
CA2698347A1 (en) * 1999-05-20 2000-11-30 Elan Pharma International Limited Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
ATE318135T1 (de) 1999-09-03 2006-03-15 Apbi Holdings Llc Verwendung von dapoxetin, a selektiver serotonin- aufnahme inhibitor mit schnellem wirkungseintritt,zur behandlung von sexueller dysfunction
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
IL150850A0 (en) * 2000-02-10 2003-02-12 Bpsi Holdings Inc Enteric coating compositions containing acrylic resin
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
EP1377276B1 (en) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Timed pulse release composition
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (en) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
PT1007024E (pt) 2003-11-28
ATE245415T1 (de) 2003-08-15
MA24585A1 (fr) 1998-12-31
SI1007024T1 (en) 2003-12-31
CN1475209A (zh) 2004-02-18
PL337799A1 (en) 2000-09-11
HN1998000099A (es) 1998-10-22
CN1261273A (zh) 2000-07-26
NO996519L (no) 2000-02-29
CN1494899A (zh) 2004-05-12
HUP0301787A3 (en) 2005-04-28
SK173299A3 (en) 2000-11-07
KR100369698B1 (ko) 2003-01-30
DZ2547A1 (fr) 2003-02-08
AP9801278A0 (en) 1998-06-30
ID23187A (id) 2000-03-23
TW575437B (en) 2004-02-11
JP2000513751A (ja) 2000-10-17
IL133081A (en) 2005-09-25
EP1007024B1 (en) 2003-07-23
NZ501249A (en) 2001-06-29
CN1475208A (zh) 2004-02-18
AR038394A2 (es) 2005-01-12
KR20010013522A (ko) 2001-02-26
AU727152B2 (en) 2000-12-07
EA001906B1 (ru) 2001-10-22
UY25068A1 (es) 2000-12-29
HK1027982A1 (en) 2001-02-02
IS5267A (is) 1999-11-23
CN1151783C (zh) 2004-06-02
EP1007024A1 (en) 2000-06-14
NO996519D0 (no) 1999-12-28
ZA985710B (en) 2000-01-10
ES2202858T3 (es) 2004-04-01
PA8454201A1 (es) 2000-09-29
BR9809895A (pt) 2000-08-01
WO1999001122A1 (en) 1999-01-14
CA2290969C (en) 2004-02-17
JP3786715B2 (ja) 2006-06-14
AU7545198A (en) 1999-01-25
PE84399A1 (es) 1999-09-11
TNSN98122A1 (fr) 2005-03-15
CA2290969A1 (en) 1999-01-14
HUP0301787A2 (hu) 2003-11-28
AP1199A (en) 2003-08-28
HRP980376A2 (en) 1999-04-30
DE69816624T2 (de) 2004-02-19
BG64742B1 (bg) 2006-02-28
UA63953C2 (uk) 2004-02-16
TR199903295T2 (xx) 2000-08-21
HRP980376B1 (en) 2002-12-31
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
DE69816624D1 (de) 2003-08-28
DK1007024T3 (da) 2003-11-17
IL133081A0 (en) 2001-03-19
BG103916A (en) 2000-07-31
EA199900965A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
US6348469B1 (en) Solid compositions containing glipizide and polyethylene oxide
US4794001A (en) Formulations providing three distinct releases
US4904476A (en) Formulations providing three distinct releases
US6576260B2 (en) Sustained-release form of administration containing tramadol saccharinate
JP3712005B2 (ja) クローン病および潰瘍性大腸炎の標的処置のための医薬組成物
JP2008303223A (ja) 脈動用量薬剤経口送達システム
IE861139L (en) Timed disintergration capsules
AU2008288106B2 (en) Extended release compositions comprising mycophenolate sodium and processes thereof
EP1007024B1 (en) Delayed-release dosage forms of sertraline
IL161628A (en) Oral pharmacy preparation containing internal and different external wraps that dissolve in a ph-dependent manner
JP2004507487A (ja) 腸疾患治療薬
JP2665858B2 (ja) 持効性塩酸オキシブチニン製剤
KR20230067636A (ko) 듀테트라베나진을 포함하는 다중미립자 제형
CZ118899A3 (cs) Kompozice s pozvolným uvolňováním léčiva, způsob přípravy této kompozice, způsob zlepšení profilu uvolňování léčiva a použití této kompozice
EP0978275A1 (en) Solid pharmaceutical dosage form with controlled drug release
MXPA99012082A (es) Formas de dosificacion de sertralina de liberacion retardada
CZ464399A3 (cs) Dávkovači formy sertralinu s řízeným uvolňováním
MXPA99002404A (es) Forma de dosis de liberacion controlada de monoclorhidrato de [r-(z)]- alfa-(metoxiimino)-alfa-(1-azabiciclo [2.2.2]oct-3-il)acetonitrilo